BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

606 related articles for article (PubMed ID: 15518817)

  • 1. Coxsackievirus B3 infection and type 1 diabetes development in NOD mice: insulitis determines susceptibility of pancreatic islets to virus infection.
    Drescher KM; Kono K; Bopegamage S; Carson SD; Tracy S
    Virology; 2004 Nov; 329(2):381-94. PubMed ID: 15518817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coxsackievirus infections and NOD mice: relevant models of protection from, and induction of, type 1 diabetes.
    Tracy S; Drescher KM
    Ann N Y Acad Sci; 2007 Apr; 1103():143-51. PubMed ID: 17376828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toward testing the hypothesis that group B coxsackieviruses (CVB) trigger insulin-dependent diabetes: inoculating nonobese diabetic mice with CVB markedly lowers diabetes incidence.
    Tracy S; Drescher KM; Chapman NM; Kim KS; Carson SD; Pirruccello S; Lane PH; Romero JR; Leser JS
    J Virol; 2002 Dec; 76(23):12097-111. PubMed ID: 12414951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Group B coxsackievirus diabetogenic phenotype correlates with replication efficiency.
    Kanno T; Kim K; Kono K; Drescher KM; Chapman NM; Tracy S
    J Virol; 2006 Jun; 80(11):5637-43. PubMed ID: 16699045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalent human coxsackie B-5 virus infects porcine islet cells primarily using the coxsackie-adenovirus receptor.
    Myers SE; Brewer L; Shaw DP; Greene WH; Love BC; Hering B; Spiller OB; Njenga MK
    Xenotransplantation; 2004 Nov; 11(6):536-46. PubMed ID: 15479464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IFN-γ induced by IL-12 administration prevents diabetes by inhibiting pathogenic IL-17 production in NOD mice.
    Zhang J; Huang Z; Sun R; Tian Z; Wei H
    J Autoimmun; 2012 Feb; 38(1):20-8. PubMed ID: 22186068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human pancreatic islet endothelial cells express coxsackievirus and adenovirus receptor and are activated by coxsackie B virus infection.
    Zanone MM; Favaro E; Ferioli E; Huang GC; Klein NJ; Perin PC; Peakman M; Conaldi PG; Camussi G
    FASEB J; 2007 Oct; 21(12):3308-17. PubMed ID: 17494992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pancreatic IL-4 expression results in islet-reactive Th2 cells that inhibit diabetogenic lymphocytes in the nonobese diabetic mouse.
    Gallichan WS; Balasa B; Davies JD; Sarvetnick N
    J Immunol; 1999 Aug; 163(3):1696-703. PubMed ID: 10415077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiviral treatment of Coxsackie B virus infection in human pancreatic islets.
    Berg AK; Olsson A; Korsgren O; Frisk G
    Antiviral Res; 2007 Apr; 74(1):65-71. PubMed ID: 17239967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coxsackievirus infection of the pancreas: evaluation of receptor expression, pathogenesis, and immunopathology.
    Mena I; Fischer C; Gebhard JR; Perry CM; Harkins S; Whitton JL
    Virology; 2000 Jun; 271(2):276-88. PubMed ID: 10860882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-4 prevents insulitis and insulin-dependent diabetes mellitus in nonobese diabetic mice by potentiation of regulatory T helper-2 cell function.
    Cameron MJ; Arreaza GA; Zucker P; Chensue SW; Strieter RM; Chakrabarti S; Delovitch TL
    J Immunol; 1997 Nov; 159(10):4686-92. PubMed ID: 9366391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of glucose transporter-2 precedes insulin loss in the nonobese diabetic and the low-dose streptozotocin mouse models: a comparative immunohistochemical study by light and confocal microscopy.
    Reddy S; Young M; Poole CA; Ross JM
    Gen Comp Endocrinol; 1998 Jul; 111(1):9-19. PubMed ID: 9653017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study on pancreatic lymphatics in nonobese diabetic mouse with prevention of insulitis and diabetes by adjuvant immunotherapy.
    Qu P; Ji RC; Shimoda H; Miura M; Kato S
    Anat Rec A Discov Mol Cell Evol Biol; 2004 Dec; 281(2):1326-36. PubMed ID: 15386276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-4 expression at the onset of islet inflammation predicts nondestructive insulitis in nonobese diabetic mice.
    Fox CJ; Danska JS
    J Immunol; 1997 Mar; 158(5):2414-24. PubMed ID: 9036992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin 12 mRNA expression in islets correlates with beta-cell destruction in NOD mice.
    Rabinovitch A; Suarez-Pinzon WL; Sorensen O
    J Autoimmun; 1996 Oct; 9(5):645-51. PubMed ID: 8933280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maternal environment affects endogenous virus induction in the offspring of type 1 diabetes model non-obese diabetic mice.
    Kagohashi Y; Udagawa J; Moriyama K; Otani H
    Congenit Anom (Kyoto); 2005 Sep; 45(3):80-4. PubMed ID: 16131364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Recombinant human IGF-1 prevents type 1 diabetes in female non-obese diabetic mice].
    Liu F; Yu M; Zhu Q
    Zhonghua Yu Fang Yi Xue Za Zhi; 2000 Sep; 34(5):281-3. PubMed ID: 11372396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential expression of coxsackievirus and adenovirus receptor on alveolar epithelial cells between fetal and adult mice determines their different susceptibility to coxsackievirus B infection.
    Sun F; Li Y; Jia T; Ling Y; Liang L; Liu G; Chen H; Chen S
    Arch Virol; 2012 Jun; 157(6):1101-11. PubMed ID: 22426860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential expression of ICAM-1 and LFA-1 versus L-selectin and VCAM-1 in autoimmune insulitis of NOD mice and association with both Th1- and Th2-type infiltrates.
    Martin S; Hibino T; Faust A; Kleemann R; Kolb H
    J Autoimmun; 1996 Oct; 9(5):637-43. PubMed ID: 8933279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Group B coxsackieviruses and autoimmunity: focus on Type 1 diabetes.
    Sané F; Moumna I; Hober D
    Expert Rev Clin Immunol; 2011 May; 7(3):357-66. PubMed ID: 21595602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.